Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
46.64B
Market cap46.64B
Price-Earnings ratio
43.32
Price-Earnings ratio43.32
Dividend yield
Dividend yield
Average volume
4.76M
Average volume4.76M
High today
$81.73
High today$81.73
Low today
$78.29
Low today$78.29
Open price
$79.55
Open price$79.55
Volume
2.57M
Volume2.57M
52 Week high
$87.89
52 Week high$87.89
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

As of today, Edwards Lifesciences(EW) shares are valued at $81.00. The company's market cap stands at 46.64B, with a P/E ratio of 43.32.

On 2026-05-13, Edwards Lifesciences(EW) stock traded between a low of $78.29 and a high of $81.73. Shares are currently priced at $81.00, which is +3.5% above the low and -0.9% below the high.

The Edwards Lifesciences(EW)'s current trading volume is 2.57M, compared to an average daily volume of 4.76M.

During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $87.89 at its peak.

During the past year, Edwards Lifesciences(EW) stock moved between $72.30 at its lowest and $87.89 at its peak.

EW News

TipRanks 5d
Edwards Lifesciences Shareholders Approve Expanded Equity Incentive Plan

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 7d
Is It Time To Reassess Edwards Lifesciences After Mixed Returns And Rich P/E Ratio

If you are wondering whether Edwards Lifesciences at around US$83.20 still offers value, the key question is how its current price stacks up against what the bu...

Is It Time To Reassess Edwards Lifesciences After Mixed Returns And Rich P/E Ratio

Analyst ratings

76%

of 34 ratings
Buy
76.5%
Hold
23.5%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.